首页> 外国专利> MEANS AND METHOD OF CONDITIONS TREATMENT IMPLYING ANDROGEN ACTION DECREASE IS CONSIDERED TO BE FAVOURABLE, AND METHOD OF ANDROGEN-DEPENDENT TISSUE SENSITIVITY ITENSIFYING USING 9-OXOACRIDINE-10-ACETIC ACID

MEANS AND METHOD OF CONDITIONS TREATMENT IMPLYING ANDROGEN ACTION DECREASE IS CONSIDERED TO BE FAVOURABLE, AND METHOD OF ANDROGEN-DEPENDENT TISSUE SENSITIVITY ITENSIFYING USING 9-OXOACRIDINE-10-ACETIC ACID

机译:认为有必要进行暗示雄激素作用降低的条件治疗的方法和方法,以及使用9-氧代磷脂酰-10-乙酸对依赖于雄激素的组织敏感性的方法

摘要

FIELD: medicine.;SUBSTANCE: invention describes application of 9-oxoacridine-10-acetic acid, it pharmaceutically acceptable salts and its ethers as additional means for treatment of conditions implying androgen action decrease is considered to be favourable, and method of condition treatment implying that androgen action decrease is considered to be favourable, and needy patient in introduced with effective amount of 9-oxoacridine-10-acetic acid it pharmaceutically acceptable salts and its ethers combined with hormonotherapy directed on androgen action decrease. Besides, method implies androgen-dependent tissue sensibility intensifying to antiandrogen hormonotherapy directed on androgen action decrease.;EFFECT: increased efficiency of antiandrogen hormonotherapy.;30 cl, 5 tbl, 9 ex
机译:领域:本发明描述了9-氧杂idine啶-10-乙酸,其药学上可接受的盐及其醚作为用于治疗暗示雄激素作用降低的病症的附加手段的用途,并且其暗示了一种病症治疗方法认为雄激素作用降低是有利的,并且向需要治疗的患者引入有效量的9-氧杂cr啶-10-乙酸,药学上可接受的盐及其醚以及针对雄激素作用的激素疗法。此外,该方法还意味着针对雄激素作用的抗雄激素激素疗法对雄激素依赖性组织的敏感性增强。效果:抗雄激素激素疗法的效率提高; 30 cl,5 tbl,9 ex

著录项

  • 公开/公告号RU2328285C2

    专利类型

  • 公开/公告日2008-07-10

    原文格式PDF

  • 申请/专利权人 EFAG AO;

    申请/专利号RU20060127808

  • 发明设计人 SURKOV KIRILL GENNADIEVICH (RU);

    申请日2006-07-31

  • 分类号A61K31/473;A61K31/706;A61P35/04;A61P13/08;A61P5/28;

  • 国家 RU

  • 入库时间 2022-08-21 19:50:35

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号